https://www.live-feeds.com/feed/snipping-a-gene-to-reduce-bad-cholesterol-for-life-looks-possibleContinuously updated, source-cited coverage. https://www.live-feeds.com/feed/snipping-a-gene-to-reduce-bad-cholesterol-for-life-looks-possiblehttps://www.live-feeds.com/feed/snipping-a-gene-to-reduce-bad-cholesterol-for-life-looks-possible#u52785Mon, 31 Aug 2026 06:06:14 +0000A first-in-human trial of CTX310, a CRISPR gene-editing therapy from CRISPR Therapeutics, demonstrated a safe and continuous reduction of LDL cholesterol and triglycerides over one year. Data presented at the ESC Congress 2026 show the treatment achieves deep and durable editing of the ANGPTL3 gene. This single-time administration suggests the possibility of reducing bad cholesterol for life. Following these Phase 1a results, CRISPR Therapeutics intends to pursue the highest dose of the lipid-lowering therapy in future development.Why it mattersHigh cholesterol and triglycerides are primary dr